These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2042 related items for PubMed ID: 31818312

  • 21. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.
    Qiao K, Liu Y, Xu Z, Zhang H, Zhang H, Zhang C, Chang Z, Lu X, Li Z, Luo C, Liu Y, Yang C, Sun T.
    Angiogenesis; 2021 Feb; 24(1):83-96. PubMed ID: 32920668
    [Abstract] [Full Text] [Related]

  • 22. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C, Wu K, Wang S, Wei G.
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [Abstract] [Full Text] [Related]

  • 23. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y, Zhao L, Li Q, Xi C, Li Y, Li Z.
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J, Tian W, Zhang W, Jia Y, Yang X, Wang Y, Zhang J.
    Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
    [Abstract] [Full Text] [Related]

  • 25. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y, Jiang T, Jia Y, Zou J, Wang X, Gu W.
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [Abstract] [Full Text] [Related]

  • 26. Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin.
    Gong S, Wang S, Shao M.
    J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
    [Abstract] [Full Text] [Related]

  • 27. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S, Wang K, Huang X, Zhao Z, Zhao Z.
    Int J Immunopathol Pharmacol; 2019 Dec; 33():2058738419859699. PubMed ID: 31240979
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou R, Zhang RG, Dong JH, Hu Y, Dong XR.
    J Hematol Oncol; 2017 Jun 19; 10(1):125. PubMed ID: 28629431
    [Abstract] [Full Text] [Related]

  • 29. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression.
    Li L, Liu D, Chen T, Wei C, Qiao Y, Liu W, Liang Y, Liang Z, Chen C, Li D, Wu B, Zhao X, Huang D, Wu D.
    J Exp Clin Cancer Res; 2024 Jul 20; 43(1):200. PubMed ID: 39030638
    [Abstract] [Full Text] [Related]

  • 30. METTL3 promotes the osteogenic differentiation of human periodontal ligament cells by increasing YAP activity via IGF2BP1 and YTHDF1-mediated m6A modification.
    Sun X, Meng X, Piao Y, Dong S, Dong Q.
    J Periodontal Res; 2024 Oct 20; 59(5):1017-1030. PubMed ID: 38838034
    [Abstract] [Full Text] [Related]

  • 31. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L, Cheng Y, Zou S, Song J.
    Thorac Cancer; 2020 Feb 20; 11(2):264-276. PubMed ID: 31793741
    [Abstract] [Full Text] [Related]

  • 32. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P, Wang Z, Hu Z, Jiao X, Yao Y.
    J Cell Biochem; 2020 Mar 20; 121(3):2632-2642. PubMed ID: 31680319
    [Abstract] [Full Text] [Related]

  • 33. The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC.
    Jin D, Guo J, Wang D, Wu Y, Wang X, Gao Y, Shao C, Xu X, Tan S.
    EBioMedicine; 2018 Nov 20; 37():188-204. PubMed ID: 30389502
    [Abstract] [Full Text] [Related]

  • 34. METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma.
    He F, Ren T, Tang X.
    Cell Mol Biol (Noisy-le-grand); 2023 Jun 30; 69(6):193-197. PubMed ID: 37605570
    [Abstract] [Full Text] [Related]

  • 35. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
    Jiang Z, Yin J, Peng G, Long X.
    Anticancer Drugs; 2021 Jan 01; 32(1):1-10. PubMed ID: 32932275
    [Abstract] [Full Text] [Related]

  • 36. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J, Min H, Yu L, Yu G, Shi Y, Sun J.
    Anticancer Drugs; 2021 Jan 01; 32(1):11-21. PubMed ID: 33290312
    [Abstract] [Full Text] [Related]

  • 37. m6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization.
    Lang C, Yin C, Lin K, Li Y, Yang Q, Wu Z, Du H, Ren D, Dai Y, Peng X.
    Clin Transl Med; 2021 Jun 01; 11(6):e426. PubMed ID: 34185427
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
    Pan H, Pan Z, Guo F, Meng F, Zu L, Fan Y, Li Y, Li M, Du X, Zhang X, Shao Y, Wei M, Li X, Zhou Q.
    BMC Cancer; 2021 Nov 13; 21(1):1218. PubMed ID: 34774019
    [Abstract] [Full Text] [Related]

  • 39. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y, Liu S, Zhao T, Dang C.
    Oncol Rep; 2021 Aug 13; 46(2):. PubMed ID: 34132367
    [Abstract] [Full Text] [Related]

  • 40. Long non-coding RNA CASC19 facilitates non-small cell lung cancer cell proliferation and metastasis by targeting the miR-301b-3p/LDLR axis.
    Wang L, Lin C, Sun N, Wang Q, Ding X, Sun Y.
    J Gene Med; 2020 Dec 13; 22(12):e3254. PubMed ID: 32677267
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 103.